1 / 20

TOC - Global AI in Healthcare Market

The artificial intelligence in healthcare is expected to grow at a CAGR of 24.40% during the forecast period from 2021 to 2030.

bisreports
Télécharger la présentation

TOC - Global AI in Healthcare Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global AI in Healthcare Market Analysis and Forecast: 2021-2030 February 2021 Table of Content

  2. Global AI in Healthcare Market BIS Research is a leading market intelligence and technology research company. BIS Research publishes in-depth market intelligence reports focusing on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom research services. Copyright © 2021 BIS Research All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all contents of this document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third party. All rights reserved at BIS Research 2

  3. Global AI in Healthcare Market T Table of able of C Contents ontents Executive Summary……………………………………………...……………. 21 1. Product Definition .............................................................................................. 33 2. Scope of Report .................................................................................................. 34 2.1 2.2 2.3 Scope of Study ............................................................................................. 34 Exclusion and Inclusion Criteria ................................................................. 36 Key Questions Answered in the Report ..................................................... 36 3. Research Methodology ...................................................................................... 38 3.1 3.2 3.3 3.4 3.5 3.6 3.7 Primary Data Sources .................................................................................. 39 Secondary Data Sources ............................................................................. 40 Data Sources Categorization ...................................................................... 41 Selection Criteria for Company Profiles ..................................................... 42 Brief Overview of the Market Estimation Process ..................................... 43 Data Validation ............................................................................................. 44 Assumptions and Limitations ..................................................................... 45 4. Industry Analysis ................................................................................................ 46 4.1 4.2 4.3 4.4 Industry Ecosystem ..................................................................................... 46 Funding Scenario ......................................................................................... 47 Readiness Index ........................................................................................... 48 Legal and Regulatory Framework ............................................................... 49 4.4.1 Regulatory Framework in North America ........................................ 49 4.4.1.1 U.S. ..................................................................................................... 49 4.4.1.1.1 Connected Devices ........................................................................ 49 4.4.1.1.2 Mobile Medical Apps (MMAs) ........................................................ 50 4.4.1.1.3 Software-as-a-Medical-Device (SaMD) .......................................... 50 4.4.1.1.3.1 General Considerations for SaMDs ..................................................... 51 4.4.2 Regulatory Framework in Europe .................................................... 53 4.4.3 Regulatory Framework in Asia-Pacific ............................................ 55 4.4.3.1 Regulatory Framework in China .......................................................... 55 All rights reserved at BIS Research 3

  4. Global AI in Healthcare Market 4.5 Patent Analysis ............................................................................................ 57 4.5.1 Insights About Awaited Technological Advancements ................. 57 4.5.1.1 Age of AI-Integrated Robotics Surgery ................................................ 57 4.5.1.2 Building an Integrated AI-Enabled Health Ecosystem ......................... 57 4.5.2 Patent Filing Trend ............................................................................ 58 5. Impact of COVID-19 on Global AI in Healthcare Market .................................. 61 5.1 Impact on Adoption of Artificial Intelligence in Healthcare ...................... 61 5.1.1 Futuristic Impact of COVID-19 on AI Adoption in Healthcare ........ 62 5.2 Key Developments During COVID-19 Pandemic ....................................... 63 5.3 Impact on Market Size of Global AI in Healthcare Market ......................... 64 5.3.1 Scenario Comparative Analysis ....................................................... 64 5.3.2 Impact on Companies in Global AI in Healthcare ........................... 65 5.4 Regional Impact ........................................................................................... 66 5.4.1 Impact of Vaccination on Regional AI Activities ............................. 68 5.5 Entry Barriers and Opportunities for Companies Entering Global AI in Healthcare Market .................................................................................... 69 6. Competitive Landscape ..................................................................................... 71 6.1 Market Share Analysis ................................................................................. 71 6.1.1 Market Share for Analysis for Medical Imaging and Diagnosis Autonomous Software Providers ................................... 72 6.1.2 Competitive Benchmarking for Drug Discovery and Clinical Trials ................................................................................................... 74 6.2 Key Developments and Strategies ............................................................. 76 6.2.1 Partnerships, Collaborations, and Agreements.............................. 78 6.2.2 New Offerings .................................................................................... 80 6.2.3 Mergers and Acquisitions ................................................................. 81 6.2.4 Funding Activities ............................................................................. 82 6.2.5 Regulatory and Legal Activities ....................................................... 83 6.3 Product Mapping Analysis .......................................................................... 84 6.4 Business Model Analysis ............................................................................ 88 6.5 Pipeline Analysis .......................................................................................... 89 All rights reserved at BIS Research 4

  5. Global AI in Healthcare Market 7. Global AI in Healthcare Market, 2019-2030 ....................................................... 92 7.1 7.2 Assumptions and Limitations ..................................................................... 92 Key Findings and Opportunity Assessment .............................................. 93 7.2.1 Key Findings ...................................................................................... 93 7.2.2 Opportunity Assessment .................................................................. 93 7.3 Market Dynamics .......................................................................................... 94 7.3.1 Market Growth-Promoting Factors .................................................. 94 7.3.1.1 Increasing Complexities of Clinical Decision-Making Leading to Higher Adoption of AI in Diagnostics ................................................... 94 7.3.1.2 Progress in Healthcare IT Leading to an Expanding Array of Applications ......................................................................................... 95 7.3.1.3 Growing Need for Patient-Centric Care ............................................... 97 7.3.1.4 Facilitation of Polypharmacology by AI ................................................ 97 7.3.1.5 Growing Applications of AI in Health Informatics ................................. 98 7.3.1.6 Shortage of Healthcare Workforce to Drive Demand for Solutions Requiring Minimum or No Human Intervention .................................... 99 7.3.2 Market Growth Inhibiting Factors .................................................. 100 7.3.2.1 Lack of Clearly Defined Regulations .................................................. 100 7.3.2.2 Data Security and Privacy Concerns ................................................. 100 7.3.2.3 Barriers to Physician's Adoption of AI ................................................ 101 7.3.2.4 Legal Implications of AI Systems ....................................................... 101 7.3.3 Market Growth Opportunities ......................................................... 102 7.3.3.1 Capitalizing on Unmet Clinical Demand ............................................ 102 7.3.3.2 Enabling Care at Home: Remote Monitoring ..................................... 102 7.3.3.3 Leveraging Rapid Development in Deep Learning ............................ 103 7.3.3.4 Unlocking the Combined Potential of AI and Robotics ...................... 104 7.3.4 Impact Analysis ............................................................................... 105 8. Global AI in Healthcare Market (by Product) .................................................. 106 8.1 8.2 8.3 Overview ..................................................................................................... 106 AI-Integrated Hardware .............................................................................. 107 Software and Services ............................................................................... 108 9. Global AI in Healthcare Market (by Technology) ........................................... 110 All rights reserved at BIS Research 5

  6. Global AI in Healthcare Market 9.1 9.2 9.3 9.4 9.5 9.6 Overview ..................................................................................................... 110 Machine Learning ....................................................................................... 111 Deep Learning ............................................................................................ 112 Computer Vision ........................................................................................ 113 Natural Language Processing (NLP) ........................................................ 115 Others ......................................................................................................... 116 10. Global AI in Healthcare Market (by Application) ............................................ 117 10.1Overview ..................................................................................................... 117 10.2Medical Imaging and Diagnosis ................................................................ 118 10.3Virtual Assistance ...................................................................................... 119 10.4Robot-Assisted Surgery ............................................................................ 120 10.5Drug Discovery and Clinical Trials ........................................................... 122 10.6Data Management ...................................................................................... 123 10.7Telemedicine .............................................................................................. 124 10.8Remote Monitoring and Lifestyle Management ....................................... 125 10.9Others ......................................................................................................... 126 11. Global AI in Healthcare Market (by End User) ................................................ 128 11.1Overview ..................................................................................................... 128 11.2Healthcare Providers ................................................................................. 129 11.3Pharmaceutical Companies ...................................................................... 130 11.4Academic Institutes and Research Centers ............................................. 131 11.5Healthcare Insurance Companies ............................................................. 132 11.6Patients ....................................................................................................... 134 11.7Others ......................................................................................................... 135 12. Global AI in Healthcare Market (by Region) ................................................... 137 12.1Overview ..................................................................................................... 137 12.2North America ............................................................................................ 138 12.2.1 North America AI in Healthcare Market (by Product) ................... 141 12.2.2 North America AI in Healthcare Market (by End User) ................. 142 12.2.3 North America AI in Healthcare Market (by Country) ................... 143 All rights reserved at BIS Research 6

  7. Global AI in Healthcare Market 12.2.3.1U.S. ................................................................................................... 143 12.2.3.2Canada .............................................................................................. 145 12.3Europe ......................................................................................................... 146 12.3.1 Europe AI in Healthcare Market (by Product) ............................... 148 12.3.2 Europe AI in Healthcare Market (by End User) ............................. 149 12.3.3 Europe AI in Healthcare Market (by Country) ............................... 150 12.3.3.1Germany ............................................................................................ 151 12.3.3.2France ............................................................................................... 152 12.3.3.3U.K. ................................................................................................... 153 12.3.3.4Italy .................................................................................................... 154 12.3.3.5Spain ................................................................................................. 156 12.3.3.6Rest-of-Europe .................................................................................. 157 12.4Asia-Pacific ................................................................................................. 158 12.4.1 Asia-Pacific AI in Healthcare Market (by Product) ........................ 160 12.4.2 Asia-Pacific AI in Healthcare Market (by End User) ..................... 161 12.4.3 Asia-Pacific AI in Healthcare Market (by Country) ....................... 162 12.4.3.1China ................................................................................................. 163 12.4.3.2Japan ................................................................................................. 164 12.4.3.3South Korea ...................................................................................... 165 12.4.3.4Australia ............................................................................................ 166 12.4.3.5India ................................................................................................... 167 12.4.3.6Rest-of-Asia-Pacific ........................................................................... 169 12.5Rest-of-the-World ....................................................................................... 170 12.5.1 Rest-of-the-World AI in Healthcare Market (by Product) .............. 172 12.5.2 Rest-of-the-World AI in Healthcare Market (by End User) ........... 173 12.5.3 Rest-of-the-World AI in Healthcare Market (by Country) ............. 174 12.5.3.1Brazil ................................................................................................. 174 12.5.3.2Mexico ............................................................................................... 175 12.5.3.3Argentina ........................................................................................... 177 12.5.3.4Rest-of-Rest-of-the-World ................................................................. 178 13. Case Studies ..................................................................................................... 180 All rights reserved at BIS Research 7

  8. Global AI in Healthcare Market 13.1Aidoc ........................................................................................................... 180 13.2Atomwise, Inc. ............................................................................................ 181 13.3Babylon Health ........................................................................................... 182 13.4Microsoft Corporation................................................................................ 183 13.5Teladoc Health, Inc. ................................................................................... 185 14. Company Profiles ............................................................................................. 187 14.1Activ Surgical Inc. ...................................................................................... 187 14.1.1 Company Overview ......................................................................... 187 14.1.2 Role of Activ Surgical Inc. in the Global AI in Healthcare Market ............................................................................................... 187 14.1.3 Recent Developments ..................................................................... 188 14.1.4 SWOT Analysis: Activ Surgical Inc. ............................................... 189 14.2Atomwise, Inc. ............................................................................................ 190 14.2.1 Company Overview ......................................................................... 190 14.2.2 Role of Atomwise, Inc. in the Global AI in Healthcare Market ..... 190 14.2.3 Recent Developments ..................................................................... 191 14.2.4 SWOT Analysis: Atomwise, Inc. ..................................................... 193 14.3Babylon Health ........................................................................................... 194 14.3.1 Overview .......................................................................................... 194 14.3.2 Role of Babylon Health in the Global AI in Healthcare Market .... 194 14.3.3 Recent Developments ..................................................................... 196 14.3.4 SWOT Analysis: Babylon Health .................................................... 197 14.4BenevolentAI .............................................................................................. 198 14.4.1 Company Overview ......................................................................... 198 14.4.2 Role of BenevolentAI in the Global AI in Healthcare Market ....... 198 14.4.3 Recent Developments ..................................................................... 199 14.4.4 SWOT Analysis: BenevolentAI ....................................................... 200 14.5Butterfly Network, Inc. ............................................................................... 201 14.5.1 Company Overview ......................................................................... 201 14.5.2 Role of Butterfly Network, Inc. in the Global AI in Healthcare Market ............................................................................................... 201 14.5.3 Recent Developments ..................................................................... 202 All rights reserved at BIS Research 8

  9. Global AI in Healthcare Market SWOT Analysis: Butterfly Network, Inc. ........................................ 203 14.6Freenome .................................................................................................... 204 14.6.1 Company Overview ......................................................................... 204 14.6.2 Role of Freenome in the Global AI in Healthcare Market ............. 204 14.6.3 Recent Developments ..................................................................... 205 14.6.4 SWOT Analysis: Freenome ............................................................. 206 14.7General Electric Company ......................................................................... 207 14.7.1 Company Overview ......................................................................... 207 14.7.2 Role of General Electric Company in the Global AI in Healthcare Market ............................................................................ 207 14.7.3 Recent Developments ..................................................................... 208 14.7.4 Financials ......................................................................................... 209 14.7.5 SWOT Analysis: General Electric Company ................................. 212 14.8International Business Machines Corporation (IBM) .............................. 213 14.8.1 Company Overview ......................................................................... 213 14.8.2 Role of International Business Machines Corporation in the Global AI in Healthcare Market ....................................................... 213 14.8.3 Recent Developments ..................................................................... 215 14.8.4 Financials ......................................................................................... 216 14.8.5 SWOT Analysis: International Business Machines Corporation ...................................................................................... 219 14.9Koninklijke Philips N.V. ............................................................................. 220 14.9.1 Company Overview ......................................................................... 220 14.9.2 Role of Koninklijke Philips N.V. in the Global AI in Healthcare Market ............................................................................ 220 14.9.3 Recent Developments ..................................................................... 221 14.9.4 Financials ......................................................................................... 222 14.9.5 SWOT Analysis: Koninklijke Philips N.V. ...................................... 225 14.10Nuance Communications, Inc. .................................................................. 226 14.10.1 Company Overview ......................................................................... 226 14.10.2 Role of Nuance Communications, Inc. in the Global AI in Healthcare Market ............................................................................ 226 14.10.3 Recent Developments ..................................................................... 227 14.5.4 All rights reserved at BIS Research 9

  10. Global AI in Healthcare Market 14.10.4 14.10.5 14.11Nvidia Corporation ..................................................................................... 232 14.11.1 Company Overview ......................................................................... 232 14.11.2 Role of Nvidia Corporation in the Global AI in Healthcare Market ............................................................................................... 232 14.11.3 Recent Developments ..................................................................... 233 14.11.4 Financials ......................................................................................... 234 14.11.5 SWOT Analysis: Nvidia Corporation .............................................. 236 14.12Olive .......................................................................................................... 237 14.12.1 Company Overview ......................................................................... 237 14.12.2 Role of Olive in the Global AI in Healthcare Market ..................... 237 14.12.3 Recent Developments ..................................................................... 238 14.12.4 SWOT Analysis: Olive ..................................................................... 239 14.13Siemens Healthineers AG .......................................................................... 240 14.13.1 Company Overview ......................................................................... 240 14.13.2 Role of Siemens Healthineers AG in the Global AI in Healthcare Market ............................................................................ 240 14.13.3 Recent Developments ..................................................................... 241 14.13.4 Financials ......................................................................................... 242 14.13.5 SWOT Analysis: Siemens Healthineers AG .................................. 245 14.14Viz.ai, Inc. .................................................................................................... 246 14.14.1 Company Overview ......................................................................... 246 14.14.2 Role of Viz.ai, Inc. in the Global AI in Healthcare Market ............. 246 14.14.3 Recent Developments ..................................................................... 247 14.14.4 SWOT Analysis: Viz.ai, Inc. ............................................................ 248 14.15Zebra Medical Vision Ltd ........................................................................... 249 14.15.1 Company Overview ......................................................................... 249 14.15.2 Role of Zebra Medical Vision Ltd in the Global AI in Healthcare Market ............................................................................ 249 14.15.3 Recent Developments ..................................................................... 251 14.15.4 SWOT Analysis: Zebra Medical Vision Ltd .................................... 252 Financials ......................................................................................... 228 SWOT Analysis: Nuance Communications, Inc. ........................... 231 All rights reserved at BIS Research 10

  11. Global AI in Healthcare Market List of Tabl List of Tables es Table 4.1: Global AI in Healthcare Market: Funding Scenario ........................................................... 47 Table 4.2: IMDRF Classification: SaMD Categories ........................................................................... 51 Table 4.3: General Considerations for SaMDs ................................................................................... 52 Table 4.4: Challenges Faced in MDR Implementation ....................................................................... 54 Table 4.5: IMDRF Risk Classification: MDR ........................................................................................ 55 Table 4.6: Regulatory Guidelines in China .......................................................................................... 56 Table 4.7: Top Five CPCs for the Patents Filed During 2015-July 2020 ........................................... 59 Table 5.1: Global AI in Healthcare Market, Impact on AI Adoption .................................................... 63 Table 5.2: Regional Impact of COVID-19 ............................................................................................ 67 Table 6.1: Global AI in Healthcare Market: Key Companies .............................................................. 71 Table 6.2: Global AI in Healthcare Market, Competitive Benchmarking, Drug Discovery and Clinical Trials, 2019 .................................................................................................................. 74 Table 6.3: Global AI in Healthcare Market: Company Product Mapping Analysis ............................. 85 Table 6.4: Global AI in Healthcare Market: Business Models ............................................................ 89 Table 6.5: Global AI in Healthcare Market: Key Product Pipeline ...................................................... 90 Table 7.1: Factors Contributing to Diagnostic Errors in Primary Care ............................................... 94 Table 11.1: Global AI in Healthcare Market: Technology Utilization by Patients ............................. 129 Table 11.2: Global AI in Healthcare Market: Technology Utilization by Patients ............................. 134 Table 12.1: Impact Analysis of Drivers and Restraints of the North America AI in Healthcare Market .................................................................................................................. 140 Table 12.2: Impact Analysis of Drivers and Restraints of the Europe AI in Healthcare Market ...... 147 Table 12.3: Impact Analysis of Drivers and Restraints of the Asia-Pacific AI in Healthcare Market .................................................................................................................. 159 Table 12.4: Impact Analysis of Drivers and Restraints of the Rest-of-the-World AI in Healthcare Market .................................................................................................................. 171 All rights reserved at BIS Research 11

  12. Global AI in Healthcare Market List of List of Figures Figures Figure 1: Global AI in Healthcare Market, 2019-2030 ......................................................................... 22 Figure 2: Key Applications of AI in Healthcare .................................................................................... 22 Figure 3: Impact Analysis of Drivers and Restraints of the Global AI in Healthcare Market.............. 23 Figure 4: Global AI in Healthcare Market, Funding Scenario, Q1-2018- Q3 2019 ............................ 24 Figure 5: Global AI in Healthcare Market: Patent Analysis (by Year), January 2015-July 2020 ....... 25 Figure 6: Global AI in Healthcare Market, Share Analysis, 2019 ....................................................... 27 Figure 7: Global AI in Healthcare Market, Share of Key Developments and Strategies, January 2015- September 2020 .............................................................................................. 28 Figure 8: Global AI in Healthcare Market (by Application), 2019 Vs. 2030 ........................................ 29 Figure 9: Global AI in Healthcare Market (by Technology), 2019 vs. 2030 ....................................... 30 Figure 10: Global Emerging AI in Healthcare Market (by Region), 2019-2030 ................................. 31 Figure 2.1: Global AI in Healthcare Market Segmentation ................................................................. 35 Figure 2.2: Regional AI in Healthcare Market Segmentation ............................................................. 36 Figure 3.1: Global AI in Healthcare Market, Research Methodology ................................................. 38 Figure 3.2: Primary Research .............................................................................................................. 39 Figure 3.3: Secondary Research ......................................................................................................... 40 Figure 3.4: Total Number of Healthcare Company Profiles ................................................................ 42 Figure 3.5: Assumptions and Limitations ............................................................................................. 45 Figure 4.1: Global AI in Healthcare Market: Industry Structure .......................................................... 46 Figure 4.2: Global AI in Healthcare Market (Technologies Readiness Index) ................................... 48 Figure 4.3: AI/ML Workflow, TPLC Approach Proposed by FDA ....................................................... 53 Figure 4.4: Building an Integrated AI-Enabled Health Ecosystem ..................................................... 58 Figure 4.5: Global AI in Healthcare Market: Patent Analysis (by Country and Year), January 2015-July 2020 ......................................................................................................................... 60 Figure 5.1: Global AI in Healthcare Market: COVID-19 Impact on AI-Adoption ................................ 61 Figure 5.2: Global AI in Healthcare Market: Key Developments During COVID-19 Pandemic ........ 64 Figure 5.3: Global AI in Healthcare Market: Growth Trend ................................................................. 65 Figure 5.4: Global AI in Healthcare Market: Companies and Key Products During COVID-19 ........ 66 Figure 5.5: Global AI in Healthcare Market: Entry Barriers and Opportunities for Companies ......... 70 Figure 6.1: Global AI in Healthcare Market, Share Analysis, 2019 .................................................... 72 All rights reserved at BIS Research 12

  13. Global AI in Healthcare Market Figure 6.2 Global AI in Healthcare Market Share Analysis for Medical Imaging and Diagnosis Autonomous Software Providers, 2019 ................................................................. 73 Figure 6.3: Global AI in Healthcare Market, Share of Key Developments and Strategies January 2015-September 2020 ............................................................................................... 77 Figure 6.4: Global AI in Healthcare Market, Key Developments (by Year) January 2015- September 2020....................................................................................................................... 78 Figure 6.5: Global AI in Healthcare Market – Key Partnerships, Collaborations, and Agreements, January 2015-September 2020 ......................................................................... 79 Figure 6.6: Global AI in Healthcare Market, Key New Offerings, January 2015- September 2020....................................................................................................................... 80 Figure 6.7: Global AI in Healthcare Market – Key Mergers and Acquisitions, January 2015- September 2020....................................................................................................................... 81 Figure 6.8: Global AI in Healthcare Market – Key Funding Activities, January 2015- September 2020....................................................................................................................... 82 Figure 6.9: Global AI in Healthcare Market – Key Regulatory and Legal Activities, January 2015-September 2020 ............................................................................................................. 84 Figure 6.10: Global AI in Healthcare Market Business Model Share Analysis, 2019 ........................ 88 Figure 7.1: Benefits of AI-Enabled Healthcare IT Solutions for Patients ............................................ 96 Figure 7.2: Some Applications of AI in Health Informatics .................................................................. 98 Figure 7.3: Remote Monitoring Devices Enabling Care at Home ..................................................... 103 Figure 7.4: AI and Robotics Combine to Benefit Several Areas in Healthcare ................................ 104 Figure 7.5: Impact Analysis of Drivers and Restraints of the Global AI in Healthcare Market ........ 105 Figure 8.1: Global AI in Healthcare Market (by Product), $Million, 2019 and 2030 ......................... 106 Figure 8.2: Global AI in Healthcare Market (AI-Integrated Hardware), $Million, 2019-2030 ........... 107 Figure 8.3: Global AI in Healthcare Market (Software and Services), $Million, 2019-2030 ............ 108 Figure 9.1: Global AI in Healthcare Market (by Technology), $Million, 2019 and 2030 .................. 110 Figure 9.2: Global AI in Healthcare Market (Machine Learning), $Million, 2019-2030 .................... 111 Figure 9.3: Global AI in Healthcare Market (Deep Learning), $Million, 2019-2030 ......................... 112 Figure 9.4: Global AI in Healthcare Market (Computer Vision), $Million, 2019-2030 ...................... 114 Figure 9.5: Global AI in Healthcare Market (Natural Language Processing), $Million, 2019-2030 .............................................................................................................................. 115 Figure 9.6: Global AI in Healthcare Market (Other Technologies), $Million, 2019-2030 ................. 116 All rights reserved at BIS Research 13

  14. Global AI in Healthcare Market Figure 10.1: Global AI in Healthcare Market (by Application), $Million, 2019 and 2030 ................. 117 Figure 10.2: Global AI in Healthcare Market (Medical Imaging and Diagnosis), $Million, 2019-2030 .............................................................................................................................. 118 Figure 10.3: Global AI in Healthcare Market (Virtual Assistance), $Million, 2019-2030 .................. 120 Figure 10.4: Global AI in Healthcare Market (Robot-Assisted Surgery), $Million, 2019-2030 ........ 121 Figure 10.5: Global AI in Healthcare Market (Drug Discovery and Clinical Trials), $Million, 2019-2030 .............................................................................................................................. 123 Figure 10.6: Global AI in Healthcare Market (Data Management), $Million, 2019-2030 ................. 124 Figure 10.7: Global AI in Healthcare Market (Telemedicine), $Million, 2019-2030 ......................... 125 Figure 10.8: Global AI in Healthcare Market (Remote Monitoring and Lifestyle Management, $Million, 2019-2030 ................................................................................................................ 126 Figure 10.9: Global AI in Healthcare Market (Other Applications), $Million, 2019-2030 ................. 127 Figure 11.1: Global AI in Healthcare Market (by End User), $Million, 2019 and 2030 .................... 128 Figure 11.2: Global AI in Healthcare Market (Healthcare Providers) $Million, 2019-2030 .............. 130 Figure 11.3: Global AI in Healthcare Market (Pharmaceutical Companies) $Million, 2019-2030 .............................................................................................................................. 131 Figure 11.4: Global AI in Healthcare Market (Academic Institutes and Research Centers) $Million, 2019-2030 ................................................................................................................ 132 Figure 11.5: Global AI in Healthcare Market (Healthcare Insurance Companies) $Million, 2019-2030 .............................................................................................................................. 133 Figure 11.6: Global AI in Healthcare Market (Patients) $Million, 2019-2030 ................................... 135 Figure 11.7: Global AI in Healthcare Market (Other End Users) $Million, 2019-2030 ..................... 136 Figure 12.1: Global AI in Healthcare Market (by Region), 2019-2030 ............................................. 137 Figure 12.2: Global AI in Healthcare Market (by Region), $Million, 2019-2030 ............................... 138 Figure 12.3: North America AI in Healthcare Market, $Million, 2019-2030 ...................................... 139 Figure 12.4: North America AI in Healthcare Market (by Product), $Million, 2019-2030 ................. 141 Figure 12.5: North America AI in Healthcare Market (by End User), $Million, 2019-2030 .............. 142 Figure 12.6: North America AI in Healthcare Market, Share Analysis (by Country), 2019 and 2030 ....................................................................................................................... 143 Figure 12.7: U.S. AI in Healthcare Market, $Million, 2019-2030 ...................................................... 144 Figure 12.8: Canada AI in Healthcare Market, $Million, 2019-2030 ................................................. 146 Figure 12.9: Europe AI in Healthcare Market, $Million, 2019-2030 .................................................. 146 All rights reserved at BIS Research 14

  15. Global AI in Healthcare Market Figure 12.10: Europe AI in Healthcare Market (by Product), $Million, 2019-2030 .......................... 148 Figure 12.11: Europe AI in Healthcare Market (by End User), $Million, 2019-2030 ........................ 149 Figure 12.12: Europe AI in Healthcare Market Share Analysis (by Country), $Million, 2019 and 2030 ....................................................................................................................... 150 Figure 12.13: Germany AI in Healthcare Market, $Million, 2019-2030 ............................................ 152 Figure 12.14: France AI in Healthcare Market, $Million, 2019-2030 ................................................ 153 Figure 12.15: U.K. AI in Healthcare Market, $Million, 2019-2030 .................................................... 154 Figure 12.16: Italy AI in Healthcare Market, $Million, 2019-2030 ..................................................... 155 Figure 12.17: Spain AI in Healthcare Market, $Million, 2019-2030 .................................................. 156 Figure 12.18: Rest-of- Europe AI in Healthcare Market, $Million, 2019-2030 ................................. 157 Figure 12.19: Asia-Pacific AI in Healthcare Market, $Million, 2019-2030 ........................................ 159 Figure 12.20: Asia-Pacific AI in Healthcare Market (by Product), $Million, 2019-2030 ................... 160 Figure 12.21: Asia-Pacific AI in Healthcare Market (by End User), $Million, 2019-2030 ................ 161 Figure 12.22: Asia-Pacific AI in Healthcare Market Share Analysis (by Country), 2019 and 2030 ....................................................................................................................... 162 Figure 12.23: China AI in Healthcare Market, $Million, 2019-2030 .................................................. 164 Figure 12.24: Japan AI in Healthcare Market, $Million, 2019-2030 ................................................. 165 Figure 12.25: South Korea AI in Healthcare Market, $Million, 2019-2030 ....................................... 166 Figure 12.26: Australia AI in Healthcare Market, $Million, 2019-2030 ............................................. 167 Figure 12.27: India AI in Healthcare Market, $Million, 2019-2030 .................................................... 168 Figure 12.28: Rest-of-Asia-Pacific AI in Healthcare Market, $Million, 2019-2030 ........................... 169 Figure 12.29: Rest-of-the-World AI in Healthcare Market, $Million, 2019-2030 .............................. 170 Figure 12.30: Rest-of-the-World AI in Healthcare Market (by Product), $Million, 2019-2030 ......... 172 Figure 12.31: Rest-of-the-World AI in Healthcare Market (by End User), $Million, 2019-2030 ...... 173 Figure 12.32: Rest-of-the-World AI in Healthcare Market Share Analysis (by Country), 2019 and 2030 ....................................................................................................................... 174 Figure 12.33: Brazil AI in Healthcare Market, $Million, 2019-2030 .................................................. 175 Figure 12.34: Mexico AI in Healthcare Market, $Million, 2019-2030 ................................................ 176 Figure 12.35: Argentina AI in Healthcare Market, $Million, 2019-2030 ............................................ 177 Figure 12.36: Rest-of-Rest-of-the-World AI in Healthcare Market, $Million, 2019-2030 ................. 179 Figure 14.1: Activ Surgical Inc.: Product Offerings for the Global AI in Healthcare Market ............. 188 Figure 14.2: SWOT Analysis: Activ Surgical Inc. .............................................................................. 189 All rights reserved at BIS Research 15

  16. Global AI in Healthcare Market Figure 14.3: Atomwise, Inc.: Product Offerings for the Global AI in Healthcare Market .................. 191 Figure 14.4: SWOT Analysis: Atomwise, Inc. .................................................................................... 193 Figure 14.5: Babylon Health: Product Offerings for the Global AI in Healthcare Market ................. 195 Figure 14.6: SWOT Analysis: Babylon Health .................................................................................. 197 Figure 14.7: BenevolentAI: Product Offerings for the Global AI in Healthcare Market .................... 198 Figure 14.8: SWOT Analysis: BenevolentAI ...................................................................................... 200 Figure 14.9: Butterfly Network, Inc.: Product Offerings for the Global AI in Healthcare Market ...... 202 Figure 14.10: SWOT Analysis: Butterfly Network, Inc. ..................................................................... 203 Figure 14.11: Freenome: Product Offerings for the Global AI in Healthcare Market ....................... 205 Figure 14.12: SWOT Analysis: Freenome ......................................................................................... 206 Figure 14.13: General Electric Company: Product Offerings for the Global AI in Healthcare Market .................................................................................................................. 208 Figure 14.14: General Electric Company: Overall Financials, 2017-2019 ....................................... 209 Figure 14.15: General Electric Company: Revenue (by Segment), 2017-2019 .............................. 210 Figure 14.16: General Electric Company: Revenue (by Region), 2017-2019 ................................. 211 Figure 14.17: SWOT Analysis: General Electric Company .............................................................. 212 Figure 14.18: International Business Machines Corporation: Product Offerings for the Global AI in Healthcare Market ......................................................................................................... 214 Figure 14.19: International Business Machines Corporation: Overall Financials, 2017-2019 ......... 216 Figure 14.20: International Business Machines Corporation: Revenue (by Segment), 2017-2019 .............................................................................................................................. 217 Figure 14.21: International Business Machines Corporation (IBM): Revenue (by Region), 2017-2019 .............................................................................................................................. 218 Figure 14.22: SWOT Analysis: International Business Machines Corporation ................................ 219 Figure 14.23: Koninklijke Philips N.V.: Product Offerings for the Global AI in Healthcare Market .................................................................................................................. 221 Figure 14.24: Koninklijke Philips N.V.: Overall Financials, 2017-2019 ............................................. 222 Figure 14.25: Koninklijke Philips N.V.: Revenue (by Segment), 2017-2019 .................................... 223 Figure 14.26: Koninklijke Philips N.V.: Revenue (by Region), 2017-2019 ....................................... 224 Figure 14.27: SWOT Analysis: Koninklijke Philips N.V. .................................................................... 225 Figure 14.28: Nuance Communications, Inc.: Product Offerings for the Global AI in Healthcare Market .................................................................................................................. 227 All rights reserved at BIS Research 16

  17. Global AI in Healthcare Market Figure 14.29: Nuance Communications, Inc.: Overall Financials, 2017-2019 ................................. 228 Figure 14.30: Nuance Communications, Inc.: Revenue (by Segment), 2017-2019 ........................ 229 Figure 14.31: Nuance Communications, Inc.: Revenue (by Region), 2017-2019 ........................... 230 Figure 14.32: SWOT Analysis: Nuance Communications, Inc. ........................................................ 231 Figure 14.33: Nvidia Corporation: Product Offerings for the Global AI in Healthcare Market ......... 233 Figure 14.34: NVIDIA Corporation: Overall Financials, 2017-2019 .................................................. 234 Figure 14.35: NVIDIA Corporation: Revenue (by Segment), 2017-2019 ......................................... 235 Figure 14.36: NVIDIA Corporation: Revenue (by Region), 2017-2019 ............................................ 235 Figure 14.37: SWOT Analysis: Nvidia Corporation ........................................................................... 236 Figure 14.38: Olive: Product Offerings for the Global AI in Healthcare Market ............................... 237 Figure 14.39: SWOT Analysis: Olive ................................................................................................. 239 Figure 14.40: Siemens Healthineers AG: Product Offerings for the Global AI in Healthcare Market .................................................................................................................. 241 Figure 14.41: Siemens Healthineers AG: Overall Financials, 2017-2019 ........................................ 242 Figure 14.42: Siemens Healthineers AG: Revenue (by Segment), 2017-2019 ............................... 243 Figure 14.43: Siemens Healthineers AG: Revenue (by Region), 2017-2019 .................................. 244 Figure 14.44: SWOT Analysis: Siemens Healthineers AG ............................................................... 245 Figure 14.45: Viz.ai, Inc.: Product Offerings for the Global AI in Healthcare Market ....................... 246 Figure 14.46: SWOT Analysis: Viz.ai, Inc. ......................................................................................... 248 Figure 14.47: Zebra Medical Vision Ltd: Product Offerings for the Global AI in Healthcare Market .................................................................................................................. 250 Figure 14.48: SWOT Analysis: Zebra Medical Vision Ltd ................................................................. 252 All rights reserved at BIS Research 17

  18. Global AI in Healthcare Market BIS BIS Research Offerings: Research Offerings: We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s digital age. We have a vision to be a leading and a preferred knowledge partner for corporates and institutions worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other innovative solutions. Know More Know More Know More Know More All rights reserved at BIS Research 18

  19. Global AI in Healthcare Market Disclaimer Disclaimer BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published, or reproduced, in whole or in part, by any medium or in any form for any purpose, without the written consent of BIS Research. The customer will not disclose the contents of the report, whether directly through any medium or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of information to generate any statistical or other information that is or will be provided to third parties, or voluntarily produce information in legal proceedings. Market reports are based on expectations, estimates, and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies. For more details regarding permission, please contact us: Email: sales@bisresearch.com Tel: +1 510 404 8135 All rights reserved at BIS Research 19

  20. Global AI in Healthcare Market BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 E-mail: info@bisresearch.com | Call Us: +1-510-404-8135 Global Delivery Center Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540 / 4261544 All rights reserved at BIS Research 20

More Related